Related references
Note: Only part of the references are listed.Genetics of familial melanoma: 20 years after CDKN2A
Lauren G. Aoude et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
MC1R gene variants and sporadic malignant melanoma susceptibility in the Canary Islands population
Elizabeth Cordoba-Lanus et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2014)
Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma
Alexandre Leon Ribeiro de Avila et al.
FAMILIAL CANCER (2014)
Unaffected family members report improvements in daily routine sun protection 2 years following melanoma genetic testing
Lisa G. Aspinwall et al.
GENETICS IN MEDICINE (2014)
Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling
Miriam Potrony et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona
Zighereda Ogbah et al.
BMC MEDICAL GENETICS (2013)
Distribution of MC1R variants among melanoma subtypes: p.R163Q is associated with lentigo maligna melanoma in a Mediterranean population
J. A. Puig-Butille et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Melanoma Genetic Counseling and Test Reporting Improve Screening Adherence Among Unaffected Carriers 2 Years Later
Lisa G. Aspinwall et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Monitoring Patients with Multiple Nevi
Susana Puig et al.
DERMATOLOGIC CLINICS (2013)
Genetic variations of patients with familial or multiple melanoma in Southern Brazil
T. C. Grazziotin et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Evaluation of PAX3 genetic variants and nevus number
Zighereda Ogbah et al.
PIGMENT CELL & MELANOMA RESEARCH (2013)
CDKN2A is the main susceptibility gene in Italian pancreatic cancer families
Paola Ghiorzo et al.
JOURNAL OF MEDICAL GENETICS (2012)
Benefits of total body photography and digital dermatoscopy (two-step method of digital follow-up'') in the early diagnosis of melanoma in patients at high risk for melanoma
Gabriel Salerni et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Melanomas Detected in a Follow-up Program Compared With Melanomas Referred to a Melanoma Unit
Gabriel Salerni et al.
ARCHIVES OF DERMATOLOGY (2011)
Association of MC1R Variants and Host Phenotypes With Melanoma Risk in CDKN2A Mutation Carriers: A GenoMEL Study
F. Demenais et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers
F. Cuellar et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
CDKN2A mutations in melanoma families from Uruguay
A. L. Borges et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Melanocortin receptor 1 variants and melanoma risk: A study of 2 European populations
Dominique Scherer et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Selection criteria for genetic assessment of patients with familial melanoma
Sancy A. Leachman et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
MC1R variants, melanoma and red hair color phenotype: A meta-analysis
Sara Raimondi et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Clinical and molecular characterization of patients at risk for hereditary melanoma in Southern Brazil
Patricia Ashton-Prolla et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Comprehensive evaluation of allele frequency differences of MC1R variants across populations
Meg R. Gerstenblith et al.
HUMAN MUTATION (2007)
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
Alisa M. Goldstein et al.
JOURNAL OF MEDICAL GENETICS (2007)
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
Alisa M. Goldstein et al.
CANCER RESEARCH (2006)
Cancer in 15-to 29-year-olds by primary site
Archie Bleyer et al.
ONCOLOGIST (2006)
The P48T germline mutation and polymorphism in the CDKN2A gene of patients with melanoma
J Huber et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Age does not appear to be a major indicator of CDKN2A or CDK4 mutations in melanoma patients in Spain
E Nagore et al.
MELANOMA RESEARCH (2005)
Role of the CDKN2A locus in patients with multiple primary melanomas
S Puig et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Sporadic multiple primary melanoma cases:: CDKN2A germline mutations with a founder effect
S Auroy et al.
GENES CHROMOSOMES & CANCER (2001)
A single genetic origin for the G101W CDKN2A mutation in 20 melanoma-prone families
P Ciotti et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
Share Paper
